Biolase Technology Inc.
Dental laser manufacturer !%Biolase Technology Inc.%! of Irvine,
Calif., has received two more patents from the US Patent and Trademark Office for
its laser technologies that treat various eye conditions, including presbyopia –
the decline of near vision in midlife. The patents are the seventh and eighth to
be issued under the “Methods for Treating Eye Conditions” patent family.
US Patent number 7,967,017 includes 29 claims and introduces a strategy for identifying
optimal treatment zones for the reversal of presbyopia. US Patent No. 7,909,040
includes 10 claims and relates to the shape of the treatment laser beam and specific
ablative patterns for treating the condition.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024